Генетические полиморфизмы системы гемостаза
https://doi.org/10.25789/YMJ.2019.65.26
Аннотация
В статье представлены основные гены системы гемостаза: FGB, FII, FV, FVII, FXIII, ITGA2, ITGB3, MTHFR, PAI-1, а также гены, имеющие отношение к системе гемостаза. Описана роль полиморфизмов данных генов в формировании патологических состояний, таких как тромбозы и тромбофилии, также рассмотрены полиморфизмы генов гемостаза, имеющие протективный эффект.
Об авторах
Ю. А. Соловьева
МИ СВФУ им. М.К. Аммосова
Россия
Россия
Соловьева Юлия Алексеевна – аспирант
Н. В. Борисова
МИ СВФУ им. М.К. Аммосова
Россия
Россия
Борисова Наталья Владимировна – д.м.н., проф.
С. С. Слепцова
МИ СВФУ им. М.К. Аммосова
Россия
Россия
Слепцова Снежана Спиридоновна – д.м.н., зав. Кафедрой
Х. А. Куртанов
ЯНЦ КМП
Россия
Россия
Куртанов Харитон Алексеевич – к.м.н., гл.н.с.-руковод. Отдела
Н. И. Павлова
ЯНЦ КМП
Россия
Россия
Павлова Надежда Ивановна – к.м.н., в.н.с.-руковод. лаб.
Н. А. Соловьева
ЯНЦ КМП
Россия
Россия
Соловьева Наталья Алексеевна – к.м.н., в.н.с.
Список литературы
1. Роль аллельных вариантов генов свертывания крови в скорости прогрессирования фиброза при хронических заболеваниях печени / Е.Е. Старостина [и др.] // Фарматека. – 2015. – № 20. – С. 17-23.
2. Слепцова С.С. Парентеральные вирусные гепатиты и их исходы в республике Саха (Якутия) / С.С. Слепцова. – М., 2017. – 208 с.
3. Assessment of genetic determinants of the association of cY’ fibrinogen in relation to cardiovascular disease / R.S. Lovely [et al.] // Arteriosclerosis, Thrombosis, and Vascular Biology. – 2011. – Vol.31. – P.2345– 2352. doi.org/10.1161/ATVBAHA.111.232710
4. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels; the coronary artery risk development in young adults (CARDIA) study / A.P. Reiner [et al.] // Journal of Thrombosis and Haemostasis. – 2006. – Vol.4. – P.1279–1287.
5. Association between polymorphisms in the coagulation factor VII gene and coronary heart disease risk in different ethnicities: a meta-analysis / X. Mo [et al.] // BMC Med Genet. – 2011. – Vol.12. – P.107. doi:10.1186/1471-2350-12-107.
6. Association Between the G20210A Polymorphism of Prothrombin Gene and Myocardial Infarction in Tunisian Population / A. Kallel [et al.] // Biochem Genet. – 2016. – Vol.54(5). – P. 653-664. doi:10.1007/s10528-016-9744-y.
7. Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: Cardiovascular Health Study / N.A. Zakai [et al.] // J Thromb Haemost. – 2011. – Vol.9(2). – P.267-274. doi:10.1111/j.1538-7836.2010.04149.x.
8. Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity / J. Song [et al.] // PLoS One. – 2016. – Vol.11(9). – P.160757. doi: 10.1371/journal.pone.0160757.
9. Barkagan Z.S. Diagnostics and controlled therapy of hemostasis disturbances. – The 2nd edition supplemented / Z.S. Barkagan, A.P. Momot. – M.: Newdiamed. – 2001. – P. 296
10. Dashti A.A. Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals / A.A. Dashti, M.M. Jadaon // Mol Biol Rep. – 2011. – Vol.38(6). – P.3623-8. doi: 10.1007/s11033-010-0474-7.
11. Dziadosz M. Global prevalence of prothrombin gene mutation G20210A and iMPLications in women’s health: a systematic review / M. Dziadosz, L.V. Baxi // Blood Coagul Fibrinolysis. – 2016. – Vol.27(5). – P. 481-9. doi: 10.1097/MBC.0000000000000562.
12. Epidemiology of factor V Leiden: clinical iMPLications / V. De Stefano [et al.] // Semin Thromb Hemost. – 1998. – Vol.24(4). – P.367-79.
13. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction / M.N. Mannila [et al.] // Thrombosis and Haemostasis. – 2006. – Vol. 95. – P.420–427.
14. Ethnic distribution of factor V Leiden in 4047 men and women. IMPLications for venous thromboembolism screening / P. M. Ridker [et al.] // JAMA. – 1997. – Vol.277(16). – P.1305-7.
15. Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations / H.T. Cronjé [et al.] // PLoS One. – 2017. – Vol.12(11). – P.187712. doi:10.1371/journal.pone.0187712.
16. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans / W. Tang [et al.] // Am J Hematol. – 2015. – Vol.90(6). – P.534-40. doi: 10.1002/ajh.24005.
17. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and IMPLicates Obesity as a Causal Risk Factor / D. Klarin [et al.] // Circ Cardiovasc Genet. – 2017. – Vol.10(2). doi:10.1161/circgenetics.116.001643.
18. Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta– analysis / J. Li [et al.] // J Assist Reprod Genet. – 2015. – Vol.32(5). – P.817-825. doi:10.1007/s10815-015-0471-9.
19. Genetic polymorphisms influencing total and γ’ fibrinogen levels and fibrin clot properties in Africans / R.C. Kotzé [et al.] // Br J Haematol. – 2015. – Vol.168(1). – P.102-112. doi:10.1111/bjh.13104.
20. Genetic variants in PLG, LPA, and SIGLEC 14 as well as smoking contribute to plasma plasminogen levels / Q. Ma [et al.] // Blood. – 2014. – Vol.124(20). – P.3155–64. doi: 10.1182/blood-2014-03-560086
21. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation / J. Huang [et al.] // Blood. – 2012. – Vol.120(24). – P.4873–81.
22. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke / R. Natesirinilkul [et al.] // J Stroke Cerebrovasc Dis. – 2014. – Vol.23(10). – P.2566-72. doi:0.1016/j.jstrokecerebrovasdis.
23. Global Hepatitis Alliance Annual Report 2017. Geneva: World Health Organization; 2017. (https://www.afro.who.int/sites/default/files/2017-06/9789241565455-eng.pdf)
24. Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association / K.C. Desch [et al.] // Proc Natl Acad Sci U S A. – 2013. – Vol.110(2). P. 588-93. doi: 10.1073/pnas.1219885110.
25. Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility / X. Shang [et al.] // Biomed Rep. – 2013. – Vol.1(4). – P. 594–598. doi: 10.3892/br.2013.93
26. Multiethnic meta-analysis of genomewide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease / M. Sabater-Lleal [et al.] // Circulation. – 2013. – Vol.128(12). – P.1310–24. doi: 10.1161/CIRCULATIONAHA.113.002251
27. Pearson T. A. How to interpret a genomewide association study / T.A. Pearson, T.A. Manolio // JAMA. — 2008. — Vol. 299, No. 11. — P. 1335—1344. — DOI:10.1001/jama.299.11.1335.
28. Poort S.R. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis / S.R. Poort [et al.] // Blood. – 1996. – Vol. 88(10). – P. 3698-703.
29. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among AsianIndian sickle cell patients / S. K. Pandey [et al.] // Clin Appl Thromb Hemost. – 2012. Vol.18(3). – P. 320-3. doi: 10.1177/1076029611425830.
30. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population / P. Angchaisuksiri [et al.] // Am J Hematol. – 2000. –Vol.65(2). – P.119-22.
31. Prothrombin G20210A (rs1799963) polymorphism increases myocardial infarction risk in an age-related manner: A systematic review and meta-analysis / C. Li [et al.] // Sci Rep. – 2017. – Vol. 7(1). P. 13550. doi:10.1038/s41598-017-13623-6.
32. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women / K.N. Kim [et al.] // Chin Med J (Engl). – 2012. – Vol.125(7). – P.1249-53.
33. Two common, functional polymorphisms in the promoter region of the b fibrinogen gene contribute to regulation of plasma fibrinogen concentration / F.M. Van’t Hooft [et al.] // Arteriosclerosis, Thrombosis, and Vascular Biology. – 1999. – Vol.19. – P.3063–3070.
34. Variant of PAI-2 gene is associated with coronary artery disease and recurrent coronary event risk in Chinese Han population / X. Li [et al.] // Lipids Health Dis. – 2015. – Vol. 16(1)4. – P.148. doi: 10.1186/s12944-015-0150-y.
35. Varied association of prothrombin G20210A polymorphism with coronary artery disease susceptibility in different ethnic groups: evidence from 15,041 cases and 21,507 controls / B. Jin [et al.] // Mol Biol Rep. – 2011. – Vol.38(4). – P. 2371. doi: 10.1007/s11033-010-0370-1
Рецензия
Для цитирования:
Соловьева Ю.А., Борисова Н.В., Слепцова С.С., Куртанов Х.А., Павлова Н.И., Соловьева Н.А. Генетические полиморфизмы системы гемостаза. Якутский медицинский журнал. 2019;(1):82-88. https://doi.org/10.25789/YMJ.2019.65.26
For citation:
Solovyova Yu.A., Borisova N.V., Sleptsova S.S., Kurtanov Kh.A., Pavlova N.I., Solovyova N.A. Genetic polymorphisms of the hemostasis system. Yakut Medical Journal. 2019;(1):82-88. https://doi.org/10.25789/YMJ.2019.65.26
Просмотров:
2
Послать статью по эл. почте 